1. 000 patient- år blandt 2. 183 kontrolpatienter (gennemsnitlig varighed af behandlingen var 5, 5 måneder for Humira og 3, 9 måneder for de kontro- lbehandlede patienter).
The rate (95% confidence interval) of non-melanoma skin cancers was 8.8 (5.7, 13.5) per 1000 patient-years among Humira-treated patients and 2.6 (0.8, 8.0) per 1,000 patient-years among control patients.